“Efficacy of Brodalumab Vs Ustekinumab by Prior TNFα Inhibitor Exposure: Post Hoc Analysis of Two Phase 3 Psoriasis Studies”. SKIN The Journal of Cutaneous Medicine, vol. 5, no. 6, Nov. 2021, p. s51, https://doi.org/10.25251/skin.5.supp.51.